Dapivirine
- Generic Name
- Dapivirine
- Drug Type
- Small Molecule
- Chemical Formula
- C20H19N5
- CAS Number
- 244767-67-7
- Unique Ingredient Identifier
- TCN4MG2VXS
- Background
Dapivirine has been investigated for the prevention of HIV-1 Infections and Topical Penile Exposures.
A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in South Africa
Phase 1
Withdrawn
- Conditions
- HIV Infections
- First Posted Date
- 2006-03-20
- Last Posted Date
- 2015-12-10
- Lead Sponsor
- International Partnership for Microbicides, Inc.
- Registration Number
- NCT00304668
A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide Gel
Phase 1
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2006-03-20
- Last Posted Date
- 2006-06-02
- Lead Sponsor
- International Partnership for Microbicides, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT00304642
- Locations
- 🇿🇦
Farmovs-Parexel, Bloemfontein, South Africa
A Safety and Tolerability Study of Dapivirine (TMC120) Vaginal Microbicide Gel
Phase 1
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2006-03-17
- Last Posted Date
- 2006-07-31
- Lead Sponsor
- International Partnership for Microbicides, Inc.
- Target Recruit Count
- 112
- Registration Number
- NCT00303576
- Locations
- 🇷🇼
Projet Ubuzima, Kigali, Rwanda
🇹🇿Kilimanjaro Reproductive Health Program, Moshi, Tanzania
🇿🇦Reproductive Health Research Unit - Sheshisani IPM Clinic, Yeoville, Johannesburg, South Africa
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath